We have shown that both APOE-ε4 and GBA mutations have an independent and additive effect on cognitive outcomes, adding to mounting evidence that these variants are key drivers of cognitive decline in PD, whilst common variants in SNCA and MAPT showed no significant impact. The gene discussed is MAPT; the disease is Parkinson disease.